More on MYGN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.18 |
|
|||
| Open | $3.18 | ||||
| 52 Wk High | $45.34 | ||||
| 52 Wk Low | $15.92 | ||||
| Day High | $3.18 | ||||
| Day Low | $3.18 | ||||
| P/E | 1.36 | ||||
| EPS | $2.33 | ||||
| Volume | 1,506 | ||||
- UBS Assumes Myriad Genetics (MYGN) at Neutral
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
- Myriad Genetics (MYGN) PT Lowered to $2.50 at Jefferies
- Myriad Genetics (MYGN) PT Lowered to $3 at Stephens
- Form 4 MYRIAD GENETICS INC For: Aug 16 Filed by: Wheeler Benjamin Richard
- Form SCHEDULE 13G/A MYRIAD GENETICS INC Filed by: GLENVIEW CAPITAL MANAGEMENT, LLC
- Form SCHEDULE 13G MYRIAD GENETICS INC Filed by: Vestal Point Capital, LP
- Form SCHEDULE 13G MYRIAD GENETICS INC Filed by: STATE STREET CORP
- Myriad Genetics (MYGN) PT Lowered to $3 at Wells Fargo
Entities mentioned with MYGN
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
